We are live on ! Find out more
PHVS icon

Pharvaris

83 hedge funds and large institutions have $1.44B invested in Pharvaris in 2025 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 39 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

388% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 8

383% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 6

82% more capital invested

Capital invested by funds: $793M → $1.44B (+$650M)

38% more funds holding

Funds holding: 6083 (+23)

33% more funds holding in top 10

Funds holding in top 10: 68 (+2)

82.66% less ownership

Funds ownership: 82.66%0% (-83%)

Holders
83
Holders Change
+23
Holders Change %
+38.33%
% of All Funds
1.09%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.1%
New
29
Increased
39
Reduced
8
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
GA
1
General Atlantic
New York
$200M +$11.1M +500,000 +7%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$160M +$21.7M +976,765 +18%
FCMI
3
Foresite Capital Management IV
California
$119M +$8.16M +368,000 +8%
VP
4
venBio Partners
California
$116M +$7.76M +350,000 +8%
Viking Global Investors
5
Viking Global Investors
Connecticut
$91.2M
EFM
6
EQT Fund Management
Luxembourg
$85.4M +$76M +3,424,609 New
BCLSI
7
Bain Capital Life Sciences Investors
Massachusetts
$79.4M -$2.71M -122,106 -4%
DM
8
Deerfield Management
New York
$60.9M +$9.43M +425,000 +21%
CC
9
Commodore Capital
New York
$60.3M +$11.2M +507,043 +27%
PBA
10
Paradigm Biocapital Advisors
New York
$45.8M +$17.1M +772,583 +73%
NHAS
11
Novo Holdings A/S
Denmark
$43.7M +$555K +25,000 +1%
Wellington Management Group
12
Wellington Management Group
Massachusetts
$43.3M +$38.5M +1,734,743 New
CAM
13
Cormorant Asset Management
Massachusetts
$34M -$2.03M -91,460 -6%
SVCM
14
Saturn V Capital Management
Texas
$22.1M +$19.7M +886,332 New
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
$20.4M +$1.1M +49,493 +6%
5VM
16
5AM Venture Management
California
$19.9M
SI
17
Sofinnova Investments
California
$18.5M +$3.42M +154,344 +26%
OCA
18
Octagon Capital Advisors
New York
$18M +$1.11M +50,000 +7%
KCM
19
Kynam Capital Management
New Jersey
$16.8M +$15M +675,000 New
VA
20
VR Adviser
New York
$16.8M -$30.5M -1,373,021 -67%
SCM
21
Soleus Capital Management
Connecticut
$16.1M -$1.91M -85,916 -12%
Balyasny Asset Management
22
Balyasny Asset Management
Illinois
$15.6M +$13.9M +625,758 New
RSCM
23
Rock Springs Capital Management
Maryland
$15.6M
Point72 Asset Management
24
Point72 Asset Management
Connecticut
$13M +$10.7M +481,769 +1,281%
BlackRock
25
BlackRock
New York
$10.3M +$4.73M +213,328 +106%

PHVS Hedge Fund Activity: Q3 2025 in Review

83 of the 7,625 institutional investors tracked by Wall St. Rank reported a position in Pharvaris (PHVS) for Q3 2025, worth a combined $1.44B — up 82% from $793M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new PHVS positions and 6 closed out — a net gain of 23 holders — while 39 added to existing stakes and 8 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $38.5M. The largest seller was VR Adviser, cutting an estimated $30.5M.

  • 83 institutional investors held Pharvaris (PHVS) as of Q3 2025, up from 60 in Q2 2025.
  • Funds reported $1.44B of Pharvaris stock for Q3 2025, up 82% quarter-over-quarter.
  • 29 funds opened new Pharvaris positions in Q3 2025 and 6 closed out, a net change of +23 holders.
  • The largest Pharvaris buyer in Q3 2025 was Wellington Management Group, an estimated $38.5M added.
  • The largest Pharvaris seller in Q3 2025 was VR Adviser, an estimated $30.5M sold.

Based on aggregated 13F filings for Q3 2025.